Endiatx, a trailblazing medical technology company, is on the verge of transforming science fiction into reality with its innovative robotic pill. In a recent interview with VentureBeat, CEO Torrey Smith shared exciting updates on their progress, nearly two years after the initial coverage of the startup's visionary endeavors.
Since its founding in 2019, Endiatx has been diligently working towards enabling the remarkable journey of miniaturized robots navigating the human body for diagnostic and therapeutic purposes. Their flagship product, the PillBot, is an ingestible robotic capsule equipped with cameras, sensors, and wireless communication capabilities. This cutting-edge device allows doctors to examine the gastrointestinal tract with unparalleled precision and control.
